Clinical Trial Update: Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) [Phase 1]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1 study of LEO 39652 Cream in adults with mild-to-moderate atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 39652 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED